The study was supported by Symbiomix. Dr. Schwebke is a consultant for Symbiomix and receives funding from Alfa Wassermann and Starpharma, among others. Dr. Hillier is coprincipal investigator of the Microbicide Trials Network, sponsored by the National Institutes of Health
- Forums
- ASX - By Stock
- SPL
- BV article
BV article, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
0.001(1.02%) |
Mkt cap ! $41.39M |
Open | High | Low | Value | Volume |
9.8¢ | 9.9¢ | 9.8¢ | $20.16K | 203.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9097 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 255005 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9097 | 0.099 |
2 | 202687 | 0.098 |
1 | 40000 | 0.096 |
2 | 1124859 | 0.095 |
3 | 172280 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 255005 | 11 |
0.105 | 245161 | 7 |
0.110 | 303882 | 7 |
0.115 | 103392 | 3 |
0.120 | 242947 | 6 |
Last trade - 11.18am 07/11/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |